The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience

Patients’ responses to breast cancer neoadjuvant chemotherapy (NACT) differ because of heterogeneous tumor characteristics. Reports about NACT progression are sporadic. Here we enrolled 1187 patients who received NACT in our cancer center between January 1, 2007, and December 31, 2016. We analyzed t...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cancer Biol Ther
मुख्य लेखकों: Zheng, Yurong, Ding, Xiaowen, Zou, Dehong, Zhang, Fanrong, Qin, Chengdong, Yang, Hongjian, Mo, Wenju, Ding, Yuqin, Yu, Yang
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Taylor & Francis 2020
विषय:
Research Paper
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515534/
https://ncbi.nlm.nih.gov/pubmed/32420815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2020.1756707
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन